Companion Animal Product & Promotions Guide

October 2019

Animal Health Solution - a Henry Schein Animal Health magazine for veterinary professionals

Issue link: https://www.e-digitaleditions.com/i/1169982

Contents of this Issue

Navigation

Page 12 of 23

Backed by the largest prospective study in diabetic cats to date, PROZINC o ers predictable glycemic control and e• cacy proven to improve clinical signs associated with diabetes. 1-3 This study also shows that remission rates with the use of PROZINC was comparable to glargine. 2 Make PROZINC your fi rst-line treatment for diabetic cats. 4–6 For more information, contact your Boehringer Ingelheim representative or visit PROZINC.us. Important Safety Information for Cats: For use in cats and dogs only. Animals presenting with severe ketoacidosis, anorexia, lethargy, and/or vomiting should be stabilized with short-acting insulin and appropriate supportive therapy until their condition is stabilized. As with all insulin products, careful patient monitoring for hypoglycemia and hyperglycemia is essential to attain and maintain adequate glycemic control and to prevent associated complications. Overdosage can result in profound hypoglycemia and death. Progestogen and glucocorticoid use should be avoided. PROZINC insulin is contraindicated in cats during episodes of hypoglycemia and in cats sensitive to protamine zinc recombinant human insulin or any other ingredients in the PROZINC product. For more information, please see full prescribing information for cats. AAHA-RECOMMENDED AND FDA-APPROVED PRODATA PROSUPPORT PROZINC 18371 References: 1. Data on fi le. Boehringer Ingelheim Animal Health USA Inc. 2. Gostelow R, Scudder C, Hazuchova K, et al. One-year prospective randomized trial comparing eŒ cacy of glargine and protamine zinc insulin in diabetic cats. In: Proceedings from the American College of Veterinary Internal Medicine Forum; June 8–10, 2017; National Harbor, MD. Abstract EN10. 3. ProZinc ® (protamine zinc recombinant human insulin) [Freedom of Information Summary]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2009. 4. Rucinsky R, Cook A, Haley S, et al. AAHA diabetes management guidelines for dogs and cats. J Am Anim Hosp Assoc. 2010;46(3):215–224. 5. American Association of Feline Practitioners. AAFP practice guidelines. https://www.catvets.com/guidelines/practice-guidelines. Accessed September 19, 2018. 6. Sparkes AH, Cannon M, Church D, et al. ISFM consensus guidelines on the practical management of diabetes mellitus in cats. J Feline Med Surg. 2015;17(3):235–250. ProZinc® is a registered trademark of Boehringer Ingelheim Animal Health USA, Inc. © 2019 Boehringer Ingelheim Animal Health USA, Inc., Duluth, GA. All rights reserved. PET-0887-PROZ0119

Articles in this issue

Links on this page

Archives of this issue

view archives of Companion Animal Product & Promotions Guide - October 2019